Rentabilitas dodolan miturut bathi resik Vaccinex (VCNX)

Tandha merek Vaccinex, Inc. (VCNX)

Vaccinex, Inc. (VCNX) management is constrained by limited liquidity despite respectable research transparency. Annual net margins reflect the business's actual profitability, with the value fixed at 0.00. A compact staff of loyal scientists and external contractors lead the company. The development of pepinemab to combat neuroinflammation in Alzheimer's and Huntington's diseases creates unique asset potential.

VCNX: Rentabilitas resik perusahaan Vaccinex Inc 04.07.2022 - 28.12.2024

Rincian analitis perusahaan Vaccinex, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:vaccinex.com - VCNX
Barang unggulan Vaccinex, Inc

Assessing the operational resilience of an asset begins with analyzing the efficiency of converting revenue into net income. For Vaccinex, Inc. (VCNX), which depends on the outcome of neurology research, this parameter is critical due to a high cash burn rate. The net margin percentage reflects the profit share of every dollar of sales, revealing whether the business is overpriced or undervalued. Sharp fluctuations on this chart signal the risks of dependency on a single drug. The stability of this metric determines the financial viability of the biopharmaceutical company.

Analisis pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|NXTC - Rentabilitas dodolan miturut bathi resik|LPTX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Rentabilitas dodolan miturut bathi resik|Synthetic Biologics (TOVX) - Margin dodolan resik|Margin resik Gritstone bio|Rentabilitas dodolan miturut bathi resik Kineta, Inc. (KA)|Margin dodolan resik NEXI|TSBX - Margin resik|Margin dodolan resik HARP (Harpoon Therapeutics, Inc.)